Akebia Therapeutics【AKBA】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

1.75

買値

1.75

売値

1.77

出来高

2,276,668

1.73 日の範囲 1.78

0.80 52 週間の範囲 2.48

時価総額

381.817M

前日終値

1.79

始値

1.78

時刻

1000

1.75

(formt)

最終取引時間

財務取引量

US$ 3,985,365

VWAP

1.7505

平均取引量 (3 か月)

2,216,383

発行済株式数

218,181,202

配当利回り

PER

-7.35

1 株当たり利益 (EPS)

-0.24

歳入

194.62M

純利益

-51.93M

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment... Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.akebia.com

本社

Wilmington, Delaware, USA

設立

Akebia Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker AKBA. The last closing price for Akebia Therapeutics was US$1.79. Over the last year, Akebia Therapeutics shares have traded in a share price range of US$ 0.80 to US$ 2.48.

Akebia Therapeutics currently has 218,181,202 shares in issue. The market capitalisation of Akebia Therapeutics is US$390.54 million. Akebia Therapeutics has a price to earnings ratio (PE ratio) of -7.35.

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass., Jan. 2, 2025 CAMBRIDGE, Mass., Jan. 2, 2025 /PRNewswire/ -- Akebia Therapeutics®...

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE, Mass., Dec. 18, 2024 CAMBRIDGE, Mass., Dec. 18, 2024 /PRNewswire/ -- Akebia...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire CAMBRIDGE, Mass., Dec. 3, 2024 CAMBRIDGE, Mass., Dec. 3, 2024 /PRNewswire/ -- Akebia Therapeutics®...

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis PR Newswire CAMBRIDGE, Mass., Dec. 3, 2024 Outcomes study...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.16	-8.37696335079	1.91	1.94	1.75	1810597	1.86384848	CS
4	-0.05	-2.77777777778	1.8	1.975	1.74	1956437	1.85440779	CS
12	0.43	32.5757575758	1.32	2.17	1.3	2216383	1.85146884	CS
26	0.765	77.6649746193	0.985	2.17	0.9849	1954459	1.60542414	CS
52	0.15	9.375	1.6	2.48	0.8	2929685	1.52680155	CS
156	-0.44	-20.0913242009	2.19	2.93	0.241	3615058	1.00183931	CS
260	-5.27	-75.0712250712	7.02	13.78	0.241	3675161	2.2304849	CS

AKBA - Frequently Asked Questions (FAQ)

What is the current Akebia Therapeutics share price?

The current share price of Akebia Therapeutics is US$ 1.75

How many Akebia Therapeutics shares are in issue?

Akebia Therapeutics has 218,181,202 shares in issue

What is the market cap of Akebia Therapeutics?

The market capitalisation of Akebia Therapeutics is USD 390.54M

What is the 1 year trading range for Akebia Therapeutics share price?

Akebia Therapeutics has traded in the range of US$ 0.80 to US$ 2.48 during the past year

What is the PE ratio of Akebia Therapeutics?

The price to earnings ratio of Akebia Therapeutics is -7.35

What is the cash to sales ratio of Akebia Therapeutics?

The cash to sales ratio of Akebia Therapeutics is 1.96

What is the reporting currency for Akebia Therapeutics?

Akebia Therapeutics reports financial results in USD

What is the latest annual turnover for Akebia Therapeutics?

The latest annual turnover of Akebia Therapeutics is USD 194.62M

What is the latest annual profit for Akebia Therapeutics?

The latest annual profit of Akebia Therapeutics is USD -51.93M

What is the registered address of Akebia Therapeutics?

The registered address for Akebia Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Akebia Therapeutics website address?

The website address for Akebia Therapeutics is www.akebia.com

Which industry sector does Akebia Therapeutics operate in?

Akebia Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
VRMEVerifyMe Inc	US$ 2.57 (52.98%)	57.81M
WKEYWISeKey International Holdings AG	US$ 10.041 (52.83%)	6.7M
DATSDatChat Inc	US$ 4.8105 (49.86%)	158.48M
CDTConduit Pharmaceuticals Inc	US$ 0.1214 (48.05%)	1.16B
INTZIntrusion Inc	US$ 2.8888 (44.44%)	40.58M
IGMSIGM Biosciences Inc	US$ 2.095 (-66.21%)	5.8M
CDTGCDT Environmental Technology Investment Holdings Ltd	US$ 1.87 (-51.30%)	2.27M
MODVModivCare Inc	US$ 6.51 (-47.88%)	2.73M
AIFUAIX Inc	US$ 0.420501 (-47.76%)	7.84M
MRSNMersana Therapeutics Inc	US$ 0.691 (-46.85%)	58.35M
CDTConduit Pharmaceuticals Inc	US$ 0.1214 (48.05%)	1.16B
NVDANVIDIA Corporation	US$ 135.91 (-3.00%)	207.32M
RGTIRigetti Computing Inc	US$ 8.9299 (-11.06%)	178.21M
VMARVision Marine Technologies Inc	US$ 2.14 (40.79%)	175.48M
DATSDatChat Inc	US$ 4.8105 (49.86%)	158.48M